107133-36-8 Perindopril erbumine AKSci V2111
 
 
Loading Please Wait...
  V2111    
Perindopril erbumine
, 98%
 
Perindopril
Perindopril tert-butylamine




IDENTITY
CAS Number:107133-36-8
MDL Number:MFCD02313824
MF:C23H43N3O5
MW:441.60
SPECIFICATIONS & PROPERTIES
Purity:98%
Physical Form:White powder
Melting Point:126-130°C
Long-Term Storage:Store long-term at 2-8°C

BIOLOGICAL INFO
Solubility:DMSO: >10 mg/mL, H2O: 10mg/mL
Application(s):Non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor; Antihypertensive Agent
Form:t-Butylamine

REVIEW

 Perindopril is a long-acting ACE inhibitor that is used to treat high blood pressure, heart failure or stable coronary artery disease.

REFERENCES
[1]Hurst M, Jarvis B: Perindopril: an updated review of its use in hypertension. Drugs. 2001;61(6):867-96.
[2] Jastrzebskal M, Widecka K, Naruszewicz M, Ciechanowicz A, Janczak-Bazan A, Foltynska A, Goracy I, Chetstowski K, Wesotowska T: Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms. Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):259-69.
[3] Parker E, Aarons L, Rowland M, Resplandy G: The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state. Eur J Pharm Sci. 2005 Sep;26(1):104-13.
[4] Simpson D, Noble S, Goa KL: Perindopril: in congestive heart failure. Drugs. 2002;62(9):1367-77; discussion 1378-9.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


RELATED PRODUCTS
V2111Perindopril erbumine
I553Perindopril

Current as of August 19, 2019


Download SDS

For research use only. Not for diagnostic or therapeutic use.
Not for human use.


CATEGORIES

 APIs and Bioactives > ACE Inhibitors


PubChem